Steris (STE) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Steris · Health Care · ref. ETF XLV · 55 calls · price $232.97
What the company does: STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally.
📈 Steris (STE) stock price
$232.97-4.8% over range
Aug 28, 25low $199.4 · high $268.65Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 3 analysts
📊 JPI status : Steris has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 STE price target & analyst consensus — price $233
The price target · all analysts combined (3 targets)
Highest target · 3 firms of 3$275+18.0%
Median target · of 3 targets$270+15.9%
Lowest target · 3 firms of 3$269+15.5%
Current price$232.97
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: UBS — 66% of its targets hit on this sector (355 calls tested). It aims for $270 (+16 %), call made on August 8, 2026, maturing on August 8, 2027 (20 d ago).
The 2 reliable analysts
$273+17 %
The 1 other firm
$269+16 %
How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $273 median. “The 1 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 3 ratings (last 6 months)
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 STE price target all
All 55 calls, one by one, with our verdict on each firm.
→ See all 55 targets, analyst by analyst💡 The best analysts on STE most reliable
Their real reliability on STE, firm by firm: who was right, who was wrong.
→ See their reliability on STEAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Steris? The JPI assistant answers using our backtest data.
💰 Steris dividend: yield, history & growth › open the full page
0.89%annual yield
That's ~$1.89 per share per year.
📈 Steris fundamentals: valuation, margins & growth › open the full page
P/E 28.5Net margin 13.3 %Revenue growth +7.3 %Fairly valued
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2023
marg. 2 %
2024
Rev +11%Profit +253%
2025
Rev −1%Profit +63%
2026
Rev +9%Profit +27%
🔎 Detailed analyses
🏛️ Which US Congress members hold Steris (STE)?
4 Congress members have disclosed STE buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
✅ Historical analyst reliability on STE
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| B of A Securities ↗ | 100% | +20.6% | 2 |
| Raymond James ↗ | 100% | +19.8% | 4 |
| Piper Sandler ↗ | 100% | +13.8% | 4 |
| JMP Securities | 79% | +7.9% | 19 |
| Keybanc ↗ | 69% | +10.8% | 16 |
| Stephens & Co. ↗ | 69% | +8.7% | 13 |
| Baird ↗ | 50% | +15.0% | 2 |
| Needham ↗ | 50% | +1.9% | 4 |
| Morgan Stanley ↗ | 0% | -4.3% | 2 |
📊 What $1,000 invested in Steris would be worth › open the full page
In short — $1,000 invested in Steris 10 years ago would be worth $2,795 today, i.e. +11%/yr on average. Best year: 2019 (+43%), worst: 2022 (-24%). Price performance, excluding dividends.
If I'd invested $1,000 in Steris
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,024 | +2% |
| 3 years ago | $1,140 | +14% |
| 5 years ago | $1,111 | +11% |
Return by year (Steris)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -17% | $831 (-17%) |
| 2025 | +23% | $1,024 (+2%) |
| 2024 | -6% | $958 (-4%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Steris
Loading news…
📋 All analyst calls on STE
Filtered on — · ✕ show all
▲ Buy · 🎯$270
Price at call : $238.91 — upside +13%
Today : $232.97 — upside +16%
🎯 on STE : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Aug 8, 27
matures : Aug 8, 27
Piper Sandler ↗
Aug 7, 26
▲ Overweight · 🎯$275
Price at call : $238.91 — upside +15%
Today : $232.97 — upside +18%
🎯 on STE : 100% (3 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
▲ Buy · 🎯$275
Price at call : $234.83 — upside +17%
Today : $232.97 — upside +18%
🎯 on STE : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
▲ Overweight · 🎯$269
Price at call : $211.1 — upside +27%
Today : $232.97 — upside +15%
🎯 on STE : 40% (5 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
in progress (365j)
matures : May 13, 27
matures : May 13, 27
Morgan Stanley ↗
Aug 8, 25
▲ Overweight · 🎯$295
Price at call : $241.62 — upside +22%
Today : $232.97 — upside +27%
Expected +22% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on STE : 0% (2 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
-1.1%
stock -1% · XLV +29%
matured Aug 8, 26
▲ Overweight · 🎯$288
Price at call : $223.69 — upside +29%
Today : $232.97 — upside +24%
Expected +29% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on STE : 40% (5 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
-5.9%
stock -6% · XLV +19%
matured Jul 22, 26
Morgan Stanley ↗
Jul 15, 25
▲ Overweight · 🎯$276
Price at call : $228.84 — upside +21%
Today : $232.97 — upside +18%
Expected +21% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on STE : 0% (2 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
-7.6%
stock -8% · XLV +19%
matured Jul 15, 26
■ Hold neutral · not a buy · 🎯$263
Price at call : $245 — gap to target +7%
Today : $232.97 — gap to target +13%
🎯 on STE : no call matured yet · 📊 on Health : 50.8% · +4.5% (380 calls)
in progress (365j)
matures : May 29, 26
matures : May 29, 26
See the other 47 calls, newest to oldest
Morgan Stanley ↗
May 19, 25
■ Equal-Weight neutral · not a buy · 🎯$260
Price at call : $250.47 — gap to target +4%
Today : $232.97 — gap to target +12%
🎯 on STE : 0% (2 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : May 19, 26
matures : May 19, 26
JMP Securities
May 16, 25
▲ Market Outperform · 🎯$280
Price at call : $252.55 — upside +11%
Today : $232.97 — upside +20%
Expected +11% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on STE : 85% (13 calls matureds) · 📊 unranked overall
-15.7%
stock -16% · XLV +8%
matured May 16, 26
Stephens & Co. ↗
May 15, 25
▲ Overweight · 🎯$250
Price at call : $251.59 — upside -1%
Today : $232.97 — upside +7%
Expected -1% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on STE : 67% (12 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
-15.4%
stock -15% · XLV +9%
matured May 15, 26
Morgan Stanley ↗
May 12, 25
■ Equal-Weight neutral · not a buy · 🎯$240
Price at call : $231.15 — gap to target +4%
Today : $232.97 — gap to target +3%
🎯 on STE : 0% (2 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : May 12, 26
matures : May 12, 26
JMP Securities
Apr 10, 25
▲ Market Outperform · 🎯$265
Price at call : $221.09 — upside +20%
Today : $232.97 — upside +14%
Expected +20% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on STE : 85% (13 calls matureds) · 📊 unranked overall
+1.7%
stock +2% · XLV +8%
matured Apr 10, 26
■ Hold neutral · not a buy
🎯 on STE : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Apr 7, 26
matures : Apr 7, 26
JMP Securities
Feb 6, 25
▲ Market Outperform · 🎯$265
Price at call : $223.23 — upside +19%
Today : $232.97 — upside +14%
Expected +19% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on STE : 85% (13 calls matureds) · 📊 unranked overall
+9.9%
stock +10% · XLV +7%
matured Feb 6, 26
Stephens & Co. ↗
Feb 6, 25
▲ Overweight · 🎯$240
Price at call : $223.23 — upside +8%
Today : $232.97 — upside +3%
Expected +8% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on STE : 67% (12 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+9.9%
stock +10% · XLV +7%
matured Feb 6, 26
Piper Sandler ↗
Feb 3, 25
▲ Overweight · 🎯$265
Price at call : $219.4 — upside +21%
Today : $232.97 — upside +14%
Expected +21% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on STE : 100% (3 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
+20.4%
stock +20% · XLV +6%
matured Feb 3, 26
JMP Securities
Nov 18, 24
▲ Market Outperform · 🎯$265
Price at call : $212 — upside +25%
Today : $232.97 — upside +14%
Expected +25% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on STE : 85% (13 calls matureds) · 📊 unranked overall
+20.2%
stock +20% · XLV +8%
matured Nov 18, 25
■ Hold neutral · not a buy
🎯 on STE : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Nov 8, 25
matures : Nov 8, 25
Stephens & Co. ↗
Nov 7, 24
▲ Overweight · 🎯$260
Price at call : $219.19 — upside +19%
Today : $232.97 — upside +12%
Expected +19% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on STE : 67% (12 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+20.4%
stock +20% · XLV -2%
matured Nov 7, 25
Piper Sandler ↗
Oct 24, 24
▲ Overweight · 🎯$260
Price at call : $224.12 — upside +16%
Today : $232.97 — upside +12%
Expected +16% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on STE : 100% (3 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
+7.5%
stock +7% · XLV -1%
matured Oct 24, 25
■ Hold neutral · not a buy
🎯 on STE : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Aug 8, 25
matures : Aug 8, 25
JMP Securities
Aug 7, 24
▲ Market Outperform · 🎯$265
Price at call : $239.68 — upside +11%
Today : $232.97 — upside +14%
Expected +11% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on STE : 85% (13 calls matureds) · 📊 unranked overall
+1.3%
stock +1% · XLV -13%
matured Aug 7, 25
Stephens & Co. ↗
Aug 7, 24
▲ Overweight · 🎯$260
Price at call : $239.68 — upside +8%
Today : $232.97 — upside +12%
Expected +8% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on STE : 67% (12 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+1.3%
stock +1% · XLV -13%
matured Aug 7, 25
JMP Securities
Jul 26, 24
▲ Market Outperform · 🎯$265
Price at call : $236.32 — upside +12%
Today : $232.97 — upside +14%
Expected +12% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on STE : 85% (13 calls matureds) · 📊 unranked overall
-4.1%
stock -4% · XLV -10%
matured Jul 26, 25
Piper Sandler ↗
May 10, 24
■ Neutral neutral · not a buy · 🎯$225
Price at call : $231.33 — gap to target -3%
Today : $232.97 — gap to target -3%
🎯 on STE : 100% (3 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : May 10, 25
matures : May 10, 25
■ Hold neutral · not a buy
🎯 on STE : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : May 10, 25
matures : May 10, 25
JMP Securities
May 9, 24
▲ Market Outperform · 🎯$265
Price at call : $231.33 — upside +15%
Today : $232.97 — upside +14%
Expected +15% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on STE : 85% (13 calls matureds) · 📊 unranked overall
+0.8%
stock +1% · XLV -5%
matured May 9, 25
■ Hold neutral · not a buy
🎯 on STE : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Apr 12, 25
matures : Apr 12, 25
Stephens & Co. ↗
Feb 9, 24
▲ Overweight · 🎯$250
Price at call : $224.94 — upside +11%
Today : $232.97 — upside +7%
Expected +11% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on STE : 67% (12 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
-0.3%
stock -0% · XLV +1%
matured Feb 8, 25
JMP Securities
Feb 8, 24
▲ Market Outperform · 🎯$265
Price at call : $224.27 — upside +18%
Today : $232.97 — upside +14%
Expected +18% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on STE : 85% (13 calls matureds) · 📊 unranked overall
+0.0%
stock +0% · XLV +2%
matured Feb 7, 25
▲ Overweight · 🎯$253
Price at call : $225.92 — upside +12%
Today : $232.97 — upside +9%
Expected +12% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on STE : 40% (5 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
-2.3%
stock -2% · XLV +3%
matured Feb 5, 25
Morgan Stanley ↗
Dec 4, 23
■ Equal-Weight neutral · not a buy · 🎯$215
Price at call : $199.27 — gap to target +8%
Today : $232.97 — gap to target -8%
🎯 on STE : 0% (2 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Dec 3, 24
matures : Dec 3, 24
JMP Securities
Nov 9, 23
▲ Market Outperform · 🎯$265
Price at call : $199.32 — upside +33%
Today : $232.97 — upside +14%
Expected +33% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on STE : 85% (13 calls matureds) · 📊 unranked overall
+11.3%
stock +11% · XLV +18%
matured Nov 8, 24
Piper Sandler ↗
Oct 27, 23
■ Neutral neutral · not a buy · 🎯$215
Price at call : $209.1 — gap to target +3%
Today : $232.97 — gap to target -8%
🎯 on STE : 100% (3 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Oct 26, 24
matures : Oct 26, 24
Piper Sandler ↗
Oct 26, 23
■ Neutral neutral · not a buy · 🎯$215
Price at call : $209.39 — gap to target +3%
Today : $232.97 — gap to target -8%
🎯 on STE : 100% (3 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Oct 25, 24
matures : Oct 25, 24
Stephens & Co. ↗
Sep 25, 23
▲ Overweight · 🎯$250
Price at call : $223.23 — upside +12%
Today : $232.97 — upside +7%
Expected +12% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on STE : 67% (12 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+5.9%
stock +6% · XLV +18%
matured Sep 24, 24
JMP Securities
Sep 1, 23
▲ Market Outperform · 🎯$265
Price at call : $230.87 — upside +15%
Today : $232.97 — upside +14%
Expected +15% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on STE : 85% (13 calls matureds) · 📊 unranked overall
+5.3%
stock +5% · XLV +17%
matured Aug 31, 24
Morgan Stanley ↗
Aug 3, 23
■ Equal-Weight neutral · not a buy · 🎯$225
Price at call : $226.01 — gap to target -0%
Today : $232.97 — gap to target -3%
🎯 on STE : 0% (2 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Aug 2, 24
matures : Aug 2, 24
▲ Overweight · 🎯$258
Price at call : $225.5 — upside +14%
Today : $232.97 — upside +11%
Expected +14% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on STE : 40% (5 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
+7.6%
stock +8% · XLV +14%
matured Aug 2, 24
JMP Securities
Aug 2, 23
▲ Market Outperform · 🎯$240
Price at call : $225.5 — upside +6%
Today : $232.97 — upside +3%
Expected +6% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on STE : 85% (13 calls matureds) · 📊 unranked overall
+7.6%
stock +8% · XLV +14%
matured Aug 1, 24
▲ Overweight · 🎯$254
Price at call : $233.02 — upside +9%
Today : $232.97 — upside +9%
Expected +9% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on STE : 40% (5 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
-0.6%
stock -1% · XLV +10%
matured Jul 24, 24
Stephens & Co. ↗
Jul 17, 23
▲ Overweight · 🎯$250
Price at call : $226.95 — upside +10%
Today : $232.97 — upside +7%
Expected +10% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on STE : 67% (12 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+0.8%
stock +1% · XLV +14%
matured Jul 16, 24
Morgan Stanley ↗
May 30, 23
■ Equal-Weight neutral · not a buy · 🎯$206
Price at call : $199.55 — gap to target +3%
Today : $232.97 — gap to target -12%
🎯 on STE : 0% (2 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : May 29, 24
matures : May 29, 24
Piper Sandler ↗
May 12, 23
■ Neutral neutral · not a buy · 🎯$200
Price at call : $210.85 — gap to target -5%
Today : $232.97 — gap to target -14%
🎯 on STE : 100% (3 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : May 11, 24
matures : May 11, 24
▲ Overweight · 🎯$235
Price at call : $210.85 — upside +11%
Today : $232.97 — upside +1%
Expected +11% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on STE : 40% (5 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
+10.3%
stock +10% · XLV +9%
matured May 11, 24
JMP Securities
May 11, 23
▲ Market Outperform · 🎯$240
Price at call : $208 — upside +15%
Today : $232.97 — upside +3%
Expected +15% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on STE : 85% (13 calls matureds) · 📊 unranked overall
+11.2%
stock +11% · XLV +8%
matured May 10, 24
Piper Sandler ↗
Apr 14, 23
■ Neutral neutral · not a buy · 🎯$197
Price at call : $186.53 — gap to target +6%
Today : $232.97 — gap to target -15%
🎯 on STE : 100% (3 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Apr 13, 24
matures : Apr 13, 24
JMP Securities
Feb 15, 23
▲ Market Outperform · 🎯$240
Price at call : $198.13 — upside +21%
Today : $232.97 — upside +3%
Expected +21% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on STE : 85% (13 calls matureds) · 📊 unranked overall
+17.6%
stock +18% · XLV +10%
matured Feb 15, 24
Piper Sandler ↗
Feb 10, 23
▲ Overweight · 🎯$215
Price at call : $192.87 — upside +11%
Today : $232.97 — upside -8%
Expected +11% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on STE : 100% (3 calls matureds) · 📊 on Health : 46.7% · -1.3% (321 calls)
+16.6%
stock +17% · XLV +9%
matured Feb 10, 24
Stephens & Co. ↗
Feb 9, 23
▲ Overweight · 🎯$220
Price at call : $192.34 — upside +14%
Today : $232.97 — upside -6%
Expected +14% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on STE : 67% (12 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+16.6%
stock +17% · XLV +10%
matured Feb 9, 24
Stephens & Co. ↗
Nov 4, 21
▲ Overweight · 🎯$270
Price at call : $222.24 — upside +21%
Today : $232.97 — upside +16%
Expected +21% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on STE : 67% (12 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
-26.7%
stock -27% · XLV -3%
matured Nov 4, 22
Stephens & Co. ↗
Aug 11, 21
▲ Overweight · 🎯$255
Price at call : $217.58 — upside +17%
Today : $232.97 — upside +9%
Expected +17% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on STE : 67% (12 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
-3.4%
stock -3% · XLV +0%
matured Aug 11, 22
Stephens & Co. ↗
Mar 23, 20
▲ Overweight · 🎯$145
Price at call : $118.11 — upside +23%
Today : $232.97 — upside -38%
Expected +23% · Actual +59% · Reason (≥ +15%) : ✓ Yes
🎯 on STE : 67% (12 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+59.0%
stock +59% · XLV +42%
matured Mar 23, 21
Stephens & Co. ↗
Feb 12, 20
▲ Overweight · 🎯$177
Price at call : $167.83 — upside +5%
Today : $232.97 — upside -24%
Expected +5% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on STE : 67% (12 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+8.6%
stock +9% · XLV +12%
matured Feb 11, 21
Frequently asked questions
Should I buy Steris stock?
This isn't buy advice. For Steris, the analyst consensus is "Buy", with an average price target of $270 (+16% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Steris). We show the numbers — you decide.
Is it too late to buy Steris? How high can it go?
The most bullish analyst target on Steris is $275 (+18% above today's price); the average is $270. That's the upside they see. Check how reliable those analysts have actually been on Steris on our site before trusting it.
Is Steris still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 9 analysts have a real record on Steris, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
What has Steris's past performance been?
Historical returns and a "how much if I had invested" calculator: STE performance & returns.
Does Steris pay a dividend?
Yield, consistency and growth history of the dividend: STE's dividend.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX